​

Funding Round

Series B - Iambic Therapeutics

Series B - Iambic Therapeutics

Investment Firm

Overview

Iambic Therapeutics is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

Announced Date

Apr 24, 2024

Closed on Date

Jun 18, 2024

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Mubadala Capital

Mubadala Capital

No designation

Participant Investors

7

Investor Name
Participant InvestorTao Capital Partners
Participant InvestorIllumina Ventures
Participant InvestorAbingworth
Participant InvestorNexus Venture Partners
Participant InvestorCoatue

Round Details and Background

Iambic Therapeutics raised $50000000 on 2024-04-24 in Series B

Iambic Therapeutics is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 14, 2021
Series A - Iambic Therapeutics
6-53.0M
Oct 03, 2023
Series B - Iambic Therapeutics
13-100.0M
Apr 24, 2024
Series B - Iambic Therapeutics
9-50.0M

Recent Activity

There is no recent news or activity for this profile.